Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances

Neurodegenerative diseases including Alzheimer’s disease,Parkinson’s disease,Huntington disease and amyotrophic lateral sclerosis throw a heavy burden on families and society. Related scientific researches make tardy progress. One reason is that the known pathogeny is just the tip of the iceberg. Another reason is that various physiological barriers,especially blood-brain barrier(BBB),hamper effective therapeutic substances from reaching site of action. Drugs in clinical treatment of neurodegenerative diseases are basically administered orally. And generally speaking,the brain targeting efficiency is pretty low. Nanodelivery technology brings hope for neurodegenerative diseases. The use of nanocarriers encapsulating molecules such as peptides and genomic medicine may enhance drug transport through the BBB in neurodegenerative disease and target relevant regions in the brain for regenerative processes. In this review,we discuss BBB composition and applications of nanocarriers-liposomes,nanoparticles,nanomicelles and new emerging exosomes in neurodegenerative diseases. Furthermore,the disadvantages and the potential neurotoxicity of nanocarriers according pharmacokinetics theory are also discussed.

脱氮微生物及脱氮工艺研究进展

脱氮是大部分污水处理系统中不可缺少的一环。由于具有经济高效、工艺简单和无二次污染等显著优势,生物脱氮工艺在最近数十年中备受关注。根据脱氮微生物的生理特性和脱氮机制不同,文中分类综述了近年来生物脱氮工艺的研究进展,重点对比分析了硝化菌、反硝化菌和厌氧氨氧化菌以及以这些菌为基础的不同生物脱氮工艺的优缺点,为复杂污水环境的脱氮工艺选择提供参考。基于微生物脱氮机制,通过合成生物学技术开发高效脱氮菌株,结合不同工艺优点并应用自动化模拟最佳条件,从而建立经济高效的脱氮工艺将是未来发展的重要方向。